Phylogenomics and metabolic engineering reveal a conserved gene cluster in Solanaceae plants for withanolide biosynthesis
Samuel Edward Hakim,
Nancy Choudhary,
Karan Malhotra,
Jian Peng,
Arne Bültemeier,
Ahmed Arafa,
Ronja Friedhoff,
Maximilian Bauer,
Jessica Eikenberg,
Claus-Peter Witte,
Marco Herde,
Philipp Heretsch,
Boas Pucker () and
Jakob Franke ()
Additional contact information
Samuel Edward Hakim: Leibniz University Hannover
Nancy Choudhary: TU Braunschweig
Karan Malhotra: Leibniz University Hannover
Jian Peng: Leibniz University Hannover
Arne Bültemeier: Leibniz University Hannover
Ahmed Arafa: Leibniz University Hannover
Ronja Friedhoff: TU Braunschweig
Maximilian Bauer: Leibniz University Hannover
Jessica Eikenberg: Leibniz University Hannover
Claus-Peter Witte: Leibniz University Hannover
Marco Herde: Leibniz University Hannover
Philipp Heretsch: Leibniz University Hannover
Boas Pucker: TU Braunschweig
Jakob Franke: Leibniz University Hannover
Nature Communications, 2025, vol. 16, issue 1, 1-20
Abstract:
Abstract Withanolides are steroidal lactones from nightshade (Solanaceae) plants with untapped drug potential due to limited availability of minor representatives caused by lack of biosynthetic pathway knowledge. Here, we combine phylogenomics with metabolic engineering to overcome this limitation. By sequencing the genome of the medicinal plant ashwagandha (Withania somnifera) and comparing it with nine Solanaceae species, we discover a conserved withanolide biosynthesis gene cluster, consisting of two sub gene clusters with differing expression patterns. We establish metabolic engineering platforms in yeast (Saccharomyces cerevisiae) and the model plant Nicotiana benthamiana to reconstitute the first five oxidations of withanolide biosynthesis, catalysed by the cytochrome P450 monooxygenases CYP87G1, CYP88C7, and CYP749B2 and a short-chain dehydrogenase/reductase, producing the aglycone of withanoside V. Enzyme functions are conserved within both sub gene clusters in W. somnifera and between W. somnifera and Physalis pruinosa. Our work sets the basis for biotechnological withanolide production to unlock their pharmaceutical potential.
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-025-61686-1 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61686-1
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-025-61686-1
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().